Trials / Completed
CompletedNCT01901120
Long-Term Specified Drug Use-results Survey of Betanis Tablets
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,263 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate the safety and efficacy of long-term use of Betanis (generic name: mirabegron), and to determine the adherence to treatment with mirabegron.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Betanis | oral |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2013-07-17
- Last updated
- 2016-11-01
Locations
8 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01901120. Inclusion in this directory is not an endorsement.